Reply: GnRHa to trigger final oocyte maturation: a time to reconsider

By Humaidan P.   Papanikolaou E.G.   Tarlatzis B.C.  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 807-808

Oxford University Press

Access to resources Recommend Favorite

GnRHa to trigger final oocyte maturation: a time to reconsider

By Youssef M.   van der Veen F.   van Wely M.  

Human Reproduction, Vol. 25, Iss. 2, 2010-02 ,pp. : 559-559

Oxford University Press

Access to resources Recommend Favorite

A prospective trial comparing oocyte donor ovarian response and recipient pregnancy rates between suppression with gonadotrophin-releasing hormone agonist (GnRHa) alone and dual suppression with a contraceptive vaginal ring and GnRH

By Martínez F.   Boada M.   Coroleu B.   Clua E.   Parera N.   Rodríguez I.   Barri P.N.  

Human Reproduction, Vol. 21, Iss. 8, 2006-08 ,pp. : 2121-2125

Oxford University Press

Access to resources Recommend Favorite

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

By Kolibianakis E.M.   Schultze-Mosgau A.   Schroer A.   van Steirteghem A.   Devroey P.   Diedrich K.   Griesinger G.  

Human Reproduction, Vol. 20, Iss. 10, 2005-10 ,pp. : 2887-2892

Oxford University Press

Access to resources Recommend Favorite

Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles

By Humaidan P.   Van Vaerenbergh I.   Bourgain C.   Alsbjerg B.   Blockeel C.   Schuit F.   Van Lommel L.   Devroey P.   Fatemi H.  

Human Reproduction, Vol. 27, Iss. 11, 2012-11 ,pp. : 3259-3272

Oxford University Press

Access to resources Recommend Favorite